OncoCyte agrees to acquire stake in Razor Genomics

OncoCyte expects the Razor test to expand its capabilities into early-stage lung cancer management. Credit: Robina Weermeijer on Unsplash.



  • OncoCyte agrees to acquire Razor Genomics